Active Ingredients (In Each Tablet)
Docusate sodium 50 mg
Sennosides 8.6 mg
The following Structured Product Label (SPL) was submitted to the FDA by Good Sense (geiss, Destin & Dunn, Inc.) for the product Stool Softener Laxative (NDC 50804-855). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredients (in each tablet), purpose, uses, do not use, ask a doctor before use if you have, stop use and ask a doctor if, if pregnant or breast-feeding,, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Docusate sodium 50 mg
Sennosides 8.6 mg
Stool softener
Stimulant laxative
you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
| adults and children 12 years and over | take 2-4 tablets daily |
| children 6 to under 12 years of age | take 1-2 tablets daily |
| children 2 to under 6 years of age | take up to 1 tablet daily |
| children under 2 | ask a doctor |
croscarmellose sodium, dibasic calcium phosphate dihydrate, FD&c blue #2 aluminum lake, FD&C red # 40 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, silicon dioxide, talc, titanium dioxide
Call 1-877-753-3935 Monday-Friday 9AM-5PM EST
Overnight Relief
Stimulant Laxative Plus
Stool Softener
Docusate sodium 50 mg
Sennosides 8.6 mg
†Compare to active ingredients in Colace® 2-IN-1
TAMPER EVIDENT: DO NOT USE IF PRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING
*This product is not manufactured or distributed by Avrio Health L.P., distributor of Colace® 2-IN-1.
Distributed by: Geiss, Destin & Dunn, Inc.,
Peachtree City, GA 30269
* Please review the disclaimer below.